{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T21:44:39Z","timestamp":1776635079805,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.suronc.2024.102103","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:52:57Z","timestamp":1720115577000},"page":"102103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity"],"prefix":"10.1016","volume":"55","author":[{"given":"Satoru","family":"Miyahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Tomimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Iwagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2024.102103_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","article-title":"Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma","volume":"125","author":"Latenstein","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.suronc.2024.102103_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.suronc.2024.102103_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jamcollsurg.2015.12.031","article-title":"Adjuvant therapy in pancreas cancer: does it influence patterns of recurrence","volume":"222","author":"Parikh","year":"2016","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","article-title":"Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"25","author":"Groot","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12885-018-4679-9","article-title":"Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior","volume":"18","author":"Sahin","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suronc.2024.102103_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.surg.2020.06.042","article-title":"Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma","volume":"169","author":"Kolbeinsson","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2024.102103_bib8","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s00268-017-4068-6","article-title":"Primary recurrence in the lung is related to favorable prognosis in patients with pancreatic cancer and postoperative recurrence","volume":"41","author":"Zheng","year":"2017","journal-title":"World J. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00595-018-1674-3","article-title":"The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy","volume":"48","author":"Yamada","year":"2018","journal-title":"Surg. Today"},{"key":"10.1016\/j.suronc.2024.102103_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.hpb.2018.12.002","article-title":"Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival","volume":"21","author":"Groot","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.suronc.2024.102103_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pan.2019.11.015","article-title":"Lung recurrence and its therapeutic strategy in patients with pancreatic cancer","volume":"20","author":"Kurahara","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2024.102103_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2024.102103_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hpb.2017.11.009","article-title":"Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer","volume":"20","author":"Daamen","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.suronc.2024.102103_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/SLA.0000000000005977","article-title":"Dynamics of serum CA19-9 in patients undergoing pancreatic cancer resection","volume":"279","author":"van Oosten","year":"2024","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib15","author":"Network"},{"key":"10.1016\/j.suronc.2024.102103_bib16","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.2147\/OTT.S145708","article-title":"Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis, Onco","volume":"10","author":"Meng","year":"2017","journal-title":"Targets Ther."},{"key":"10.1016\/j.suronc.2024.102103_bib17","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1097\/SLA.0000000000004148","volume":"275","author":"Kato","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.surg.2016.08.005","article-title":"Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma","volume":"161","author":"Xu","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2024.102103_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/SLA.0b013e31829b3ce4","article-title":"Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer","volume":"258","author":"Takahashi","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib20","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1245\/s10434-019-07735-8","article-title":"A prospective, open-label, multicenter phase 2 trial of neoadjuvant therapy using full-dose gemcitabine and S-1 concurrent with radiation for resectable pancreatic ductal adenocarcinoma","volume":"26","author":"Eguchi","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s13063-021-05541-w","volume":"22","author":"Yamada","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.suronc.2024.102103_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000658-198808000-00014","article-title":"Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head","volume":"208","author":"Ishikawa","year":"1988","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.suronc.2024.102103_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.suronc.2024.102103_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0b013e31823d813c","article-title":"Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer","volume":"255","author":"Takahashi","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(196111\/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H","article-title":"A biomathematical approach to clinical tumor growth","volume":"14","author":"Schwartz","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2024.102103_bib27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.ejso.2020.06.013","article-title":"Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis","volume":"46","author":"Guerra","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib28","doi-asserted-by":"crossref","unstructured":"K. Hayashi, Y. Ono, M. Takamatsu, A. Oba, H. Ito, T. Sato, Y. Inoue, A. Saiura, Y. Takahashi, Prediction of recurrence pattern of pancreatic cancer post-pancreatic surgery using histology-based supervised machine learning algorithms: a single-center retrospective study, Ann. Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-022-11471-x. .","DOI":"10.1245\/s10434-022-11471-x"},{"key":"10.1016\/j.suronc.2024.102103_bib29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00423-023-03009-w","article-title":"Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma","volume":"408","author":"Shibata","year":"2023","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12957-020-02058-5","article-title":"Time interval-based indication for liver resection of metastasis from pancreatic cancer","volume":"18","author":"Mitsuka","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pan.2019.01.023","article-title":"CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection","volume":"19","author":"Li","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2024.102103_bib33","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41598-020-57930-x","article-title":"CA19-9 for detecting recurrence of pancreatic cancer","volume":"10","author":"Azizian","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.suronc.2024.102103_bib34","first-page":"131","article-title":"Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT, J. Gastrointest","volume":"14","author":"Sperti","year":"2010","journal-title":"Surgery (St Louis)"},{"key":"10.1016\/j.suronc.2024.102103_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association","volume":"270","author":"Al-Hawary","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.suronc.2024.102103_bib36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.suronc.2024.102103_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1245\/s10434-011-2152-y","article-title":"Surveillance of pancreatic cancer patients after surgical resection","volume":"19","author":"Sheffield","year":"2012","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib38","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1245\/s10434-013-2889-6","article-title":"Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis","volume":"20","author":"Tzeng","year":"2013","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/jcm8081115","article-title":"Postoperative imaging and tumor marker surveillance in resected pancreatic cancer","volume":"8","author":"Wu","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.suronc.2024.102103_bib40","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.19.00946","article-title":"Potentially curable pancreatic adenocarcinoma: ASCO clinical practice guideline update","volume":"37","author":"Khorana","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 5","key":"10.1016\/j.suronc.2024.102103_bib41","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pan.2015.10.013","article-title":"International association of pancreatology (IAP)\/european pancreatic club (EPC) consensus review of guidelines for the treatment of pancreatic cancer","volume":"16","author":"Takaori","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2024.102103_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.suronc.2020.08.005","article-title":"Metachronous hepatic resection for liver only pancreatic metastases","volume":"35","author":"Schwarz","year":"2020","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib44","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1097\/SLA.0000000000005879","volume":"278","author":"Takahashi","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2024.102103_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3389\/fonc.2020.01220","article-title":"Circulating tumor DNA as a potential marker to detect minimal residual disease and predict recurrence in pancreatic cancer","volume":"10","author":"Jiang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4251\/wjgo.v15.i4.632","article-title":"Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer","volume":"15","author":"Ko","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.suronc.2024.102103_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/clinchem\/hvac214","article-title":"Peripheral and portal venous KRAS ctDNA detection as independent prognostic markers of early tumor recurrence in pancreatic ductal adenocarcinoma","volume":"69","author":"Nitschke","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.suronc.2024.102103_bib48","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/BF01536670","article-title":"Elevated serum levels of tumor marker CA19-9 in acute cholangitis","volume":"33","author":"Albert","year":"1988","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.suronc.2024.102103_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1507\/endocrj.EJ17-0380","article-title":"Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study","volume":"65","author":"Murakami","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.suronc.2024.102103_bib50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(73)90975-6","article-title":"Increased carcinoembryonic antigen in heavy cigarette smokers","volume":"2","author":"Stevens","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.suronc.2024.102103_bib51","first-page":"916","article-title":"Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure","volume":"24","author":"Witherspoon","year":"1983","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.suronc.2024.102103_bib52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s13304-024-01758-x","article-title":"Diagnostic impact of postoperative CA19-9 dynamics on pancreatic cancer recurrence: a single-institution retrospective study","volume":"76","author":"Imamura","year":"2024","journal-title":"Updates Surg."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740424000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740424000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T04:36:27Z","timestamp":1723523787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740424000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":52,"alternative-id":["S0960740424000719"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2024.102103","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2024.102103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102103"}}